Last reviewed · How we verify
BALI association — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
BALI association (BALI association) — EMS. BALI is a fixed-dose combination association designed to treat a specific therapeutic indication through synergistic action of its component drugs.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| BALI association TARGET | BALI association | EMS | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- BALI association CI watch — RSS
- BALI association CI watch — Atom
- BALI association CI watch — JSON
- BALI association alone — RSS
Cite this brief
Drug Landscape (2026). BALI association — Competitive Intelligence Brief. https://druglandscape.com/ci/bali-association. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab